Intense Treatment Regimen With Intravitreal Aflibercept Injection

NCT03594461 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-Related Macular Degeneration

Interventions

DRUG: Aflibercept Injection

Sponsor

Vitreous -Retina- Macula Consultants of New York